We are live on ! Find out more
DNTH icon

Dianthus Therapeutics
DNTH

92 hedge funds and large institutions have $255M invested in Dianthus Therapeutics in 2020 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 35 increasing their positions, 25 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 25

17% more capital invested

Capital invested by funds: $217M → $255M (+$37.9M)

0.07% more ownership

Funds ownership: 4.14% → 4.21% (+0.07%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

2% less funds holding

Funds holding: 94 → 92 (-2)

13% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 8

72% less call options, than puts

Call options by funds: $46K | Put options by funds: $164K

Holders
92
Holders Change
-2
Holders Change %
-2.13%
% of All Funds
1.63%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
7
Increased
35
Reduced
25
Closed
8
Calls
$46K
Puts
$164K
Net Calls
-$118K
Net Calls Change
-$32K

Top Buyers

1
ACM
Aquilo Capital Management
California
+$9.27M
2
JP Morgan Chase
JP Morgan Chase
New York
+$1.51M
3
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
+$1.13M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$960K
5
PIM
Platinum Investment Management
Australia
+$834K

Top Sellers

1
EAM
Eventide Asset Management
Massachusetts
-$9.63M
2
Renaissance Technologies
Renaissance Technologies
New York
-$1.05M
3
PM
Prosight Management
Texas
-$840K
4
Squarepoint
Squarepoint
New York
-$376K
5
UBS AM
UBS AM
Illinois
-$368K
Name Holding Trade Value Shares
Change 		Change in
Stake
Royal Bank of Canada
76
Royal Bank of Canada
Ontario, Canada
$24K +$6.8K +60 +48%
Legal & General Group
77
Legal & General Group
United Kingdom
$19K – – –
Ohio Public Employees Retirement System (OPERS)
78
Ohio Public Employees Retirement System (OPERS)
Ohio
$17K +$15.6K +138 New
AIP
79
Ameritas Investment Partners
Nebraska
$13K – – –
TRCT
80
Tower Research Capital (TRC)
New York
$12K -$40K -353 -79%
HPC
81
HM Payson & Co
Maine
$11K -$2.38K -21 -19%
Simplex Trading
82
Simplex Trading
Illinois
$10K -$17.5K -154 -64%
SO
83
STRS Ohio
Ohio
$9K – – –
Osaic Holdings
84
Osaic Holdings
Arizona
$8K – – –
PCM
85
Penserra Capital Management
California
$8K +$4.88K +43 +165%
PHK
86
Point72 Hong Kong
Hong Kong
$6K -$2.61K -23 -33%
BDWM
87
Brewin Dolphin Wealth Management
Ireland
$4.31K – – –
Daiwa Securities Group
88
Daiwa Securities Group
Japan
$1K -$794 -7 -50%
AF
89
Advisornet Financial
Minnesota
$1K – – –
AIG
90
American International Group
New York
$94 -$2.49K -22 -3%
Tudor Investment Corp
91
Tudor Investment Corp
Connecticut
– -$200K -1,842 Closed
Arrowstreet Capital
92
Arrowstreet Capital
Massachusetts
– -$183K -1,679 Closed
Prudential Financial
93
Prudential Financial
New Jersey
– -$128K -1,176 Closed
EGM
94
Engineers Gate Manager
New York
– -$82K -756 Closed
PFS
95
Prospera Financial Services
Texas
– -$23K -216 Closed
PAM
96
Panagora Asset Management
Massachusetts
– -$20K -184 Closed
Group One Trading
97
Group One Trading
Illinois
– -$5.67K -50 Closed
LC
98
Lindbrook Capital
California
– -$2K -20 Closed
EI
99
Ellevest Inc
New York
– -$454 -4 -80%
1 2 3
4

DNTH Hedge Fund Activity: Q4 2020 in Review

92 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Dianthus Therapeutics (DNTH) for Q4 2020, worth a combined $255M — up 17% from $217M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of DNTH and 7 opened new positions — a net loss of 1 holder — while 25 trimmed existing stakes and 35 added.

The largest buyer was Aquilo Capital Management, adding an estimated $9.27M. The largest seller was Eventide Asset Management, cutting an estimated $9.63M.

  • 92 institutional investors held Dianthus Therapeutics (DNTH) as of Q4 2020, down from 94 in Q3 2020.
  • Funds reported $255M of Dianthus Therapeutics stock for Q4 2020, up 17% quarter-over-quarter.
  • 7 funds opened new Dianthus Therapeutics positions in Q4 2020 and 8 closed out, a net change of -1 holder.
  • The largest Dianthus Therapeutics buyer in Q4 2020 was Aquilo Capital Management, an estimated $9.27M added.
  • The largest Dianthus Therapeutics seller in Q4 2020 was Eventide Asset Management, an estimated $9.63M sold.

Based on aggregated 13F filings for Q4 2020.